The Lancet. Global health, Vol. 10, no. 2, p. e227-e235 (2022) The Lancet. Global Health investigators, PRENT S & Dark, P 2022, ' Geoeconomic variations in epidemiology, ventilation management, and outcomes in invasively ventilated intensive care unit patients without acute respiratory distress syndrome: a pooled analysis of four observational studies. ', The Lancet Global health, vol. 10, no. 2, pp. e227-e235 . https://doi.org/10.1016/S2214-109X(21)00485-X Lancet Global Health, 10, 2, pp. e227-e235 PRoVENT study investigators, LUNG SAFE study investigators, ERICC study investigators & PRoVENT-iMiC study investigators 2022, ' Geoeconomic variations in epidemiology, ventilation management, and outcomes in invasively ventilated intensive care unit patients without acute respiratory distress syndrome : a pooled analysis of four observational studies ', The Lancet Global Health, vol. 10, no. 2, pp. e227-e235 . https://doi.org/10.1016/S2214-109X(21)00485-X The Lancet Global Health, 10(2), e227-e235. Elsevier BV Lancet Global Health, 10, e227-e235 lancet global health, 10(2), e227-e235. Elsevier BV
McAuley, D 2020, ' Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19:The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical Trial ', JAMA : the journal of the American Medical Association . https://doi.org/10.1001/jama.2020.17022 JAMA : the journal of the American Medical Association Jama : Journal of the American Medical Association, 324, 1317-1329 Angus, D & Bradbury, C A 2020, ' Effect of Hydrocortisone on Mortality and Organ Support in Patients with Severe COVID-19 : The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical Trial ', JAMA-Journal of the American Medical Association, vol. 324, no. 13, pp. 1317-1329 . https://doi.org/10.1001/jama.2020.17022 Jama : Journal of the American Medical Association, 324, 13, pp. 1317-1329 JAMA Writing Committee for the REMAP-CAP Investigators 2020, ' Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19 : The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical Trial ', JAMA, vol. 324, no. 13, pp. 1317-1329 . https://doi.org/10.1001/jama.2020.17022 JAMA, 324(13), 1317-1329. American Medical Association